BMY (Bristol-Myers Squibb Co) Dividend Payout Ratio: 0.40 (As of Mar. 2026) — Near Median

What is Bristol-Myers Squibb Co Dividend Payout Ratio?

Bristol-Myers Squibb Co BMY -2.05% 78 Dividend Payout Ratio is 0.40 as of Mar. 2026, which is 5% above its 10-year median of 0.38. GuruFocus rates BMY with a GF Score™ of 78/100 and a GF Value™ of $55.16 (Fairly Valued). The stock has 6 warning signs investors should review. Among 444 Drug Manufacturers companies, Bristol-Myers Squibb Co ranks worse than 55.18% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Bristol-Myers Squibb Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.40.

The historical rank and industry rank for Bristol-Myers Squibb Co's Dividend Payout Ratio or its related term are showing as below:

BMY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.27 Med: 0.38 Max: 2.1
Current: 0.42

During the past 13 years, the highest Dividend Payout Ratio of Bristol-Myers Squibb Co was 2.10. The lowest was 0.27. And the median was 0.38.

BMY's Dividend Payout Ratio is ranked worse than
55.18% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.375 vs BMY: 0.42

As of today (2026-07-01), the Dividend Yield % of Bristol-Myers Squibb Co is 4.46%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Bristol-Myers Squibb Co was 5.98%. The lowest was 1.99%. And the median was 3.05%.

Bristol-Myers Squibb Co's Dividends per Share for the months ended in Mar. 2026 was $0.63.

During the past 12 months, Bristol-Myers Squibb Co's average Dividends Per Share Growth Rate was 2.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 4.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 6.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 6.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bristol-Myers Squibb Co was 14.20% per year. The lowest was 0.00% per year. And the median was 3.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Bristol-Myers Squibb Co (NYSE:BMY) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Bristol-Myers Squibb Co Dividend Payout Ratio Related Terms

Bristol-Myers Squibb Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Bristol-Myers Squibb Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co Dividend Payout Ratio Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividend Payout Ratio

Get a 7-Day Free Trial

0.27

0.28

0.31

2.10

0.41

Bristol-Myers Squibb Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividend Payout Ratio	Get a 7-Day Free Trial															0.34	0.43	0.38	0.50	0.40

BMY vs PFE, GILD, AMGN: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Dividend Payout Ratio falls into.

Save Embed

78GF Score

Bristol-Myers Squibb Co BMY

Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bristol-Myers Squibb Co Dividend Payout Ratio Calculation

Bristol-Myers Squibb Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2025 )	/	EPS without NRI (A: Dec. 2025 )
	=	2.49	/	6.15
	=	0.40

Bristol-Myers Squibb Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	0.63	/	1.58
	=	0.40

Frequently Asked Questions Learn more about Dividend Payout Ratio →

What does a Dividend Payout Ratio of 0.40 mean?

Bristol-Myers Squibb Co (BMY) has a Dividend Payout Ratio of 0.40 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bristol-Myers Squibb Co and its competitors. This is near median its historical median of 0.38. Over the past decade, Bristol-Myers Squibb Co's Dividend Payout Ratio has ranged from 0.27 to 2.10. According to the industry distribution chart, Bristol-Myers Squibb Co ranks #245 out of 444 companies in the Drug Manufacturers industry, placing it in the top 55.2%.

Is Bristol-Myers Squibb Co's Dividend Payout Ratio too high?

Bristol-Myers Squibb Co's current Dividend Payout Ratio of 0.40 is near median its 10-year median of 0.38. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 2.10. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Bristol-Myers Squibb Co's value of 0.40 is 6.7% above this industry median. Based on the distribution chart, Bristol-Myers Squibb Co ranks #245 out of 444 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Bristol-Myers Squibb Co has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Bristol-Myers Squibb Co's Dividend Payout Ratio compare to PFE and GILD?

According to the Drug Manufacturers industry distribution chart, Bristol-Myers Squibb Co ranks #245 out of 444 companies for Dividend Payout Ratio. This places Bristol-Myers Squibb Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Bristol-Myers Squibb Co's value of 0.40 is 6.7% above this benchmark. Historically, Bristol-Myers Squibb Co's own Dividend Payout Ratio has ranged from 0.27 to 2.10 over the past decade. While the company's 10-year median is 0.38 vs. the industry median of 0.38, Bristol-Myers Squibb Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividend Payout Ratio for a Drug Manufacturers company?

The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bristol-Myers Squibb Co's current Dividend Payout Ratio of 0.40 is 6.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividend Payout Ratio mean?

A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bristol-Myers Squibb Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bristol-Myers Squibb Co's current Dividend Payout Ratio is 0.40, which is near median its own 10-year median of 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bristol-Myers Squibb Co stock overvalued right now?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co (BMY) is currently considered Fairly Valued. The stock's GF Value™ is $55.16, compared to a current price of $56.44 — trading 2.3% above its estimated fair value. The current Dividend Payout Ratio is 0.40, which is near median its 10-year median of 0.38 and 6.7% above the Drug Manufacturers industry median of 0.38. Bristol-Myers Squibb Co's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividend Payout Ratio calculated?

Dividend Payout Ratio is calculated from a company's financial statements. For Bristol-Myers Squibb Co (BMY), the current Dividend Payout Ratio is 0.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bristol-Myers Squibb Co (BMY) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of $56.44 is trading 2.3% above its estimated GF Value™ of $55.16. GuruFocus considers Bristol-Myers Squibb Co to be Fairly Valued.

Key valuation signals for BMY:

Dividend Payout Ratio: 0.40 (near median its 10-year median of 0.38)
GF Value™: $55.16 vs. price of $56.44 (2.3% above fair value)
GF Score™: 78/100 with 6 warning signs
Industry Position: 6.7% above the Drug Manufacturers median (#245 of 444)

No single metric tells the full story. See the BMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bristol-Myers Squibb Co Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies PFE GILD AMGN BIIB OGN AMRN SCLX MIRA NSRX MDCX LLY JNJ ABBV XSWX:ROP MRK XSWX:NOVN LSE:AZN OCSE:NOVO B LSE:GSK XPAR:SAN

Other Exchanges BMY:Peru BMY:Mexico 1BMY:Italy 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website https://www.bms.com

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

78GF Score

Get the complete analysis for BMY

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$56.44

Price

$55.16

GF Value

View BMY Analysis

See Dividend Payout Ratio data for all stocks →